You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SIRT

Showing 1 - 25 of 215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo

Recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • SIRT-Y90 with Atezolizumab + Bevacizumab
  • SIRT-Y90 with Placebo (IV)
  • Singapore, Singapore
  • +1 more
Jan 26, 2023

Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023

SIRT1(rs7069102 ) Gene Polymorphism in Chronic Obstructive

Recruiting
  • Genotyping of SIRT1in Chronic Obstructive Pulmonary Disease
  • genotyping of SIRT1 in chronic obstructive patients
  • Sohag, Egypt
    Sohag university Hospital
Sep 20, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, sintilimab plus SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))

Recruiting
  • Neuroendocrine Tumors
  • Liver Metastases
  • TheraSpheres Selective Internal Radiation Therapy (SIRT)
  • London, United Kingdom
    Imperial College NHS Trust
Mar 8, 2022

Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Yttrium-90 carbon microspheres SIRT
  • Nanjing, China
    Gao-Jun Teng
Jul 20, 2023

Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma Trial in Ann Arbor (drug, device, radiation, diagnostic

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Unresectable Hepatocellular Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021

Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Dresden, Germany
  • +7 more
Apr 13, 2022

Aggressive Hepatocellular Carcinomas Treated Using SIRT

Completed
  • Hepatocellular Carcinoma
    • Montpellier, France
      Uhmontpellier
    Sep 29, 2021

    Hepatocellular Carcinoma Trial in France (QuiremSpheres)

    Recruiting
    • Hepatocellular Carcinoma
    • QuiremSpheres
    • Clichy, France
    • +3 more
    Jan 27, 2023

    Cholangio Carcinoma Trial in Hong Kong (SIRT Yttrium-90)

    Active, not recruiting
    • Cholangio Carcinoma
    • SIRT Yttrium-90
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Prince of Wales Hospital
    May 3, 2022

    Endometriosis, Uterine Diseases, Endometrial Diseases Trial in Winston-Salem (EX-527 (Selisistat), Placebo)

    Withdrawn
    • Endometriosis
    • +4 more
    • EX-527 (Selisistat)
    • Placebo
    • Winston-Salem, North Carolina
      Wake Forest School of Medicine
    Nov 8, 2021

    Hepatectomy Trial in Cologne (SIRT followed by liver resection or liver transplantation)

    Recruiting
    • Hepatectomy
    • SIRT followed by liver resection or liver transplantation
    • Cologne, Germany
      University of Cologne, Department of General, Visceral and Cance
    Mar 1, 2022

    Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

    Recruiting
    • Unresectable Colorectal Liver Metastases
    • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
    • Nanjing, Jiangsu, China
      Zhongda Hospital Southeast University
    Jan 26, 2023

    Cancer Trial in Manchester (Y90-PET-CT scan)

    Recruiting
    • Cancer
    • Y90-PET-CT scan
    • Manchester, United Kingdom
      The Christie NHS - Nuclear Medicine Department
    Nov 7, 2023

    Uveal Melanoma Trial in Berlin (SIRT, DSM-TACE)

    Recruiting
    • Uveal Melanoma
    • SIRT
    • DSM-TACE
    • Berlin, Germany
      Charité - University Medicine Berlin, Dept. of Haematology, Medi
    Nov 8, 2021

    Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

    Not yet recruiting
    • Bile Duct Cancer
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 23, 2023

    90Y Resin Micropheres for Refractory Colorectal Cancer Liver

    Recruiting
    • Liver Metastasis Colon Cancer
      • Aarhus N, Danmark, Denmark
        Department of Oncology, Aarhus University Hospital
      Feb 14, 2022

      Liver Cancer, Liver Metastasis Colon Cancer, Primary Liver Cancer Trial (Fractional administration device)

      Not yet recruiting
      • Liver Cancer
      • +2 more
      • Fractional administration device
      • (no location specified)
      Jan 13, 2022

      Hepatic Malignancies Trial in Cleveland (PET/CT, PET/MR, SIRT with Y-90)

      Completed
      Has Results
      • Hepatic Malignancies
      • PET/CT
      • +2 more
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Jun 1, 2022

      Intrahepatic Cholangiocarcinoma Trial in Worldwide (Cisplatin-gemcitabine, Radiation: SIRT + chemo (cisplatin-gemcitabine))

      Active, not recruiting
      • Intrahepatic Cholangiocarcinoma
      • Spokane, Washington
      • +22 more
      Apr 1, 2022

      Liver, Cancer of, Non-Resectable Trial in Dresden, Utrecht (Selective Internal Radiation Therapy with QuiremSpheres®)

      Terminated
      • Liver, Cancer of, Non-Resectable
      • Selective Internal Radiation Therapy with QuiremSpheres®
      • Dresden, Germany
      • +1 more
      Mar 25, 2021

      Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United

      Recruiting
      • Unresectable Hepatocellular Carcinoma (HCC)
      • Liver Metastases From Colorectal Cancer (mCRC)
      • SIRT
      • Clichy, Cedex, France
      • +8 more
      Jul 31, 2023

      Holmium-166 Retrospective Collection of Real-World Data

      Completed
      • Hepatocellular Carcinoma
      • Metastatic Cancer
      • Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
      • Aalst, Belgium
      • +11 more
      Aug 29, 2022